Table 5:
Open in new tab

5-year cumulative incidence of cardiac and noncardiac events at follow-up

Variables5-year cumulative incidence, % (95% CI)
P-value5-year cumulative incidence, % (95% CI)
P-value
Group 1PSM (n = 75)Group 2PSM (n = 77)Group 1 (n = 110)Group 2 (n = 156)
Prosthesis-associated complications, total16.9 (9.5–26.2)0<0.00117 (10.7–24.6)0<0.001
Mitral valve prostheses16.9 (9.5–26.2)0<0.00116.1 (10.0–23.6)0<0.001
Biological prostheses2.6 (0.5–8.2)00.1571.8 (0.3–5.7)00.12
Mechanical prostheses14.3 (7.6–23.2)00.00315.2 (9.3–22.6)0<0.001
Cardioembolic complications7.8 (3.2–15.2)00.0466.3 (2.7–11.8)00.008
PPM implantation2.6 (0.5–8.2)2.6 (0.5–8.3)1.002.7 (0.7–7.0)1.3 (0.3–4.3)0.59
Malignancies2.6 (0.5–8.2)4.2 (1.1–10.9)0.661.8 (0.3–5.7)4.4 (1.8–8.9)0.29
Sudden cardiac death6.5 (2.4–13.5)1.8 (0.1–8.6)0.325.4 (2.2–10.6)1.1 (0.1–5.3)0.13
Cardiac cause of death13 (6.6–21.6)3.8 (0.7–11.7)0.0511.6 (6.5–18.3)3.1 (0.8–8.3)0.019
Non-cardiac cause of death7.8 (3.2–15.2)11.4 (3.6–24.2)0.746.3 (2.7–11.8)9.6 (3.7–19.0)0.55
Variables5-year cumulative incidence, % (95% CI)
P-value5-year cumulative incidence, % (95% CI)
P-value
Group 1PSM (n = 75)Group 2PSM (n = 77)Group 1 (n = 110)Group 2 (n = 156)
Prosthesis-associated complications, total16.9 (9.5–26.2)0<0.00117 (10.7–24.6)0<0.001
Mitral valve prostheses16.9 (9.5–26.2)0<0.00116.1 (10.0–23.6)0<0.001
Biological prostheses2.6 (0.5–8.2)00.1571.8 (0.3–5.7)00.12
Mechanical prostheses14.3 (7.6–23.2)00.00315.2 (9.3–22.6)0<0.001
Cardioembolic complications7.8 (3.2–15.2)00.0466.3 (2.7–11.8)00.008
PPM implantation2.6 (0.5–8.2)2.6 (0.5–8.3)1.002.7 (0.7–7.0)1.3 (0.3–4.3)0.59
Malignancies2.6 (0.5–8.2)4.2 (1.1–10.9)0.661.8 (0.3–5.7)4.4 (1.8–8.9)0.29
Sudden cardiac death6.5 (2.4–13.5)1.8 (0.1–8.6)0.325.4 (2.2–10.6)1.1 (0.1–5.3)0.13
Cardiac cause of death13 (6.6–21.6)3.8 (0.7–11.7)0.0511.6 (6.5–18.3)3.1 (0.8–8.3)0.019
Non-cardiac cause of death7.8 (3.2–15.2)11.4 (3.6–24.2)0.746.3 (2.7–11.8)9.6 (3.7–19.0)0.55

CI: confidence interval; PSM: propensity score matching.

Table 5:
Open in new tab

5-year cumulative incidence of cardiac and noncardiac events at follow-up

Variables5-year cumulative incidence, % (95% CI)
P-value5-year cumulative incidence, % (95% CI)
P-value
Group 1PSM (n = 75)Group 2PSM (n = 77)Group 1 (n = 110)Group 2 (n = 156)
Prosthesis-associated complications, total16.9 (9.5–26.2)0<0.00117 (10.7–24.6)0<0.001
Mitral valve prostheses16.9 (9.5–26.2)0<0.00116.1 (10.0–23.6)0<0.001
Biological prostheses2.6 (0.5–8.2)00.1571.8 (0.3–5.7)00.12
Mechanical prostheses14.3 (7.6–23.2)00.00315.2 (9.3–22.6)0<0.001
Cardioembolic complications7.8 (3.2–15.2)00.0466.3 (2.7–11.8)00.008
PPM implantation2.6 (0.5–8.2)2.6 (0.5–8.3)1.002.7 (0.7–7.0)1.3 (0.3–4.3)0.59
Malignancies2.6 (0.5–8.2)4.2 (1.1–10.9)0.661.8 (0.3–5.7)4.4 (1.8–8.9)0.29
Sudden cardiac death6.5 (2.4–13.5)1.8 (0.1–8.6)0.325.4 (2.2–10.6)1.1 (0.1–5.3)0.13
Cardiac cause of death13 (6.6–21.6)3.8 (0.7–11.7)0.0511.6 (6.5–18.3)3.1 (0.8–8.3)0.019
Non-cardiac cause of death7.8 (3.2–15.2)11.4 (3.6–24.2)0.746.3 (2.7–11.8)9.6 (3.7–19.0)0.55
Variables5-year cumulative incidence, % (95% CI)
P-value5-year cumulative incidence, % (95% CI)
P-value
Group 1PSM (n = 75)Group 2PSM (n = 77)Group 1 (n = 110)Group 2 (n = 156)
Prosthesis-associated complications, total16.9 (9.5–26.2)0<0.00117 (10.7–24.6)0<0.001
Mitral valve prostheses16.9 (9.5–26.2)0<0.00116.1 (10.0–23.6)0<0.001
Biological prostheses2.6 (0.5–8.2)00.1571.8 (0.3–5.7)00.12
Mechanical prostheses14.3 (7.6–23.2)00.00315.2 (9.3–22.6)0<0.001
Cardioembolic complications7.8 (3.2–15.2)00.0466.3 (2.7–11.8)00.008
PPM implantation2.6 (0.5–8.2)2.6 (0.5–8.3)1.002.7 (0.7–7.0)1.3 (0.3–4.3)0.59
Malignancies2.6 (0.5–8.2)4.2 (1.1–10.9)0.661.8 (0.3–5.7)4.4 (1.8–8.9)0.29
Sudden cardiac death6.5 (2.4–13.5)1.8 (0.1–8.6)0.325.4 (2.2–10.6)1.1 (0.1–5.3)0.13
Cardiac cause of death13 (6.6–21.6)3.8 (0.7–11.7)0.0511.6 (6.5–18.3)3.1 (0.8–8.3)0.019
Non-cardiac cause of death7.8 (3.2–15.2)11.4 (3.6–24.2)0.746.3 (2.7–11.8)9.6 (3.7–19.0)0.55

CI: confidence interval; PSM: propensity score matching.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close